NEU 1.54% $15.32 neuren pharmaceuticals limited

Successful, page-8

  1. 709 Posts.
    lightbulb Created with Sketch. 277
    Very Very good result today. A positive effect, still getting greater at end of treatment and in, arguably, the least likely (ie older) group to respond. Obviously good for this condition but we now have support of human response from the drug - with the follow on of more confidence in the other trials.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.